Track topics on Twitter Track topics that are important to you
Callitas Health (CSE:LILY, OTCQB:MPHMF) CEO James Thompson tells Proactive Investors the health and wellness company is planning on launching its patent-pending CannaMint strips in the next 2 months or so, the strips would deliver THC orally.
Thompson says the company is currently producing samples and adding THC to the strips, he says the firm is planning to license the technology to manufacturers and distributors in North America.
Thompson added the company has a new partner, to be announced, partnering with Callitas to help distribute the company's arousal gels.NEXT ARTICLE
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...